BRF (BRFS3) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
26 Dec, 2025Executive summary
Achieved record first-quarter results with net income of R$1.2 billion, up nearly 100% year-over-year, and net revenue of R$15.5 billion, a 16% increase, driven by operational efficiencies, market diversification, and strong brand performance in Brazil and international markets.
Adjusted EBITDA reached R$2.8 billion, up 30% year-over-year, with a margin of 17.7% and 65% cash conversion, marking the lowest historical leverage at 0.54x.
Free cash flow rose to R$1.3 billion, or R$1.8 billion excluding the Addoha acquisition, and net debt reduced to R$5,982 million, supporting continued investment and financial discipline.
Strategic acquisitions in China and Saudi Arabia, new plant construction in Jeddah, and 12 new export permits reinforced value-added product growth and regional leadership.
Employee engagement reached 89%, with top ESG rankings in animal welfare and sustainability indices.
Financial highlights
Net revenue grew 16% year-over-year to R$15.5 billion; gross profit increased 25.7% to R$4.1 billion, with a gross margin of 26.1%-28.1%.
Adjusted EBITDA of R$2.8 billion, up 30% year-over-year, with a margin of 17.7%.
Net income doubled to R$1.2 billion; free cash flow was R$1.3 billion, up 52% year-over-year.
Net debt reduced by 28.1% sequentially to R$5,982 million; leverage at 0.54x EBITDA, lowest in company history.
Operating income rose 54.2% to R$1,887 million; operating margin increased 3.1 p.p. to 12.2%.
Outlook and guidance
Management expects continued volume and margin growth, supported by investments in capacity, efficiency, and innovation.
Anticipate 3%-5% additional growth as new facilities mature; focus on value-added product expansion and market diversification.
Domestic demand and pricing remain strong and stable into Q2 2025; export markets show stable volumes and prices.
Latest events from BRF
- Record 2Q24: net income R$1.1B, EBITDA R$2.6B, leverage at nine-year low.BRFS3
Q2 20241 Feb 2026 - Record 3Q24: revenue up 12.4%, net income BRL 1.1B, leverage at historic low.BRFS3
Q3 202414 Jan 2026 - Record 2024 results: revenue, profit, and cash flow up, leverage down, global growth advanced.BRFS3
Q4 202427 Dec 2025 - Merger with Marfrig and record EBITDA highlight robust growth despite export challenges.BRFS3
Q2 202523 Nov 2025 - Record sales and revenue growth, but lower profit and margins amid higher costs and export bans.BRFS3
Q3 202517 Nov 2025